• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁的获取和代谢作为抗菌药物的有前途的靶点(瓶颈和机遇):我们处于什么位置?

Iron Acquisition and Metabolism as a Promising Target for Antimicrobials (Bottlenecks and Opportunities): Where Do We Stand?

机构信息

Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Via A. Ferrata 9, 27100 Pavia, Italy.

Department of Pharmaceutical Sciences, University of Milan, Via L. Mangiagalli 25, 20133 Milano, Italy.

出版信息

Int J Mol Sci. 2023 Mar 24;24(7):6181. doi: 10.3390/ijms24076181.

DOI:10.3390/ijms24076181
PMID:37047161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10094389/
Abstract

The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) infections is one of the most crucial challenges currently faced by the scientific community. Developments in the fundamental understanding of their underlying mechanisms may open new perspectives in drug discovery. In this review, we conducted a systematic literature search in PubMed, Web of Science, and Scopus, to collect information on innovative strategies to hinder iron acquisition in bacteria. In detail, we discussed the most interesting targets from iron uptake and metabolism pathways, and examined the main chemical entities that exhibit anti-infective activities by interfering with their function. The mechanism of action of each drug candidate was also reviewed, together with its pharmacodynamic, pharmacokinetic, and toxicological properties. The comprehensive knowledge of such an impactful area of research will hopefully reflect in the discovery of newer antibiotics able to effectively tackle the antimicrobial resistance issue.

摘要

多药耐药(MDR)和广泛耐药(XDR)感染的出现是科学界目前面临的最关键挑战之一。对其潜在机制的基础理解的发展可能会为药物发现开辟新的视角。在本综述中,我们在 PubMed、Web of Science 和 Scopus 中进行了系统的文献检索,以收集有关阻碍细菌中铁摄取的创新策略的信息。详细地,我们讨论了来自铁摄取和代谢途径的最有趣的靶点,并研究了通过干扰其功能表现出抗感染活性的主要化学实体。还回顾了每个候选药物的作用机制及其药效学、药代动力学和毒理学特性。对这一有影响力的研究领域的全面了解有望反映在发现能够有效解决抗微生物药物耐药性问题的新型抗生素方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ce/10094389/8fd020d95a82/ijms-24-06181-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ce/10094389/f0bbac35cbe0/ijms-24-06181-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ce/10094389/ceb9fd3637e2/ijms-24-06181-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ce/10094389/99618e5d2e27/ijms-24-06181-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ce/10094389/719b76b48728/ijms-24-06181-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ce/10094389/6999636df906/ijms-24-06181-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ce/10094389/00a5b68dcd9c/ijms-24-06181-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ce/10094389/142fdd82c65d/ijms-24-06181-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ce/10094389/a7e44a883bc7/ijms-24-06181-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ce/10094389/8fd020d95a82/ijms-24-06181-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ce/10094389/f0bbac35cbe0/ijms-24-06181-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ce/10094389/ceb9fd3637e2/ijms-24-06181-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ce/10094389/99618e5d2e27/ijms-24-06181-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ce/10094389/719b76b48728/ijms-24-06181-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ce/10094389/6999636df906/ijms-24-06181-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ce/10094389/00a5b68dcd9c/ijms-24-06181-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ce/10094389/142fdd82c65d/ijms-24-06181-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ce/10094389/a7e44a883bc7/ijms-24-06181-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90ce/10094389/8fd020d95a82/ijms-24-06181-g009.jpg

相似文献

1
Iron Acquisition and Metabolism as a Promising Target for Antimicrobials (Bottlenecks and Opportunities): Where Do We Stand?铁的获取和代谢作为抗菌药物的有前途的靶点(瓶颈和机遇):我们处于什么位置?
Int J Mol Sci. 2023 Mar 24;24(7):6181. doi: 10.3390/ijms24076181.
2
A review on antimicrobial botanicals, phytochemicals and natural resistance modifying agents from Apocynaceae family: Possible therapeutic approaches against multidrug resistance in pathogenic microorganisms.综述:夹竹桃科植物的抗菌植物药、植物化学物质和天然耐药性调节剂:针对病原微生物多药耐药性的可能治疗方法。
Drug Resist Updat. 2020 Jul;51:100695. doi: 10.1016/j.drup.2020.100695. Epub 2020 Apr 8.
3
Iron metabolism: a promising target for antibacterial strategies.铁代谢:抗菌策略的一个有前景的靶点。
Recent Pat Antiinfect Drug Discov. 2009 Nov;4(3):190-205. doi: 10.2174/157489109789318514.
4
Harnessing microbial iron chelators to develop innovative therapeutic agents.利用微生物铁螯合剂开发创新治疗药物。
J Adv Res. 2022 Jul;39:89-101. doi: 10.1016/j.jare.2021.10.010. Epub 2021 Nov 1.
5
Advances in Engineered Nano-Biosensors for Bacteria Diagnosis and Multidrug Resistance Inhibition.用于细菌诊断和多药耐药性抑制的工程纳米生物传感器的进展。
Biosensors (Basel). 2024 Jan 23;14(2):59. doi: 10.3390/bios14020059.
6
Resistance-proof antimicrobial drug discovery to combat global antimicrobial resistance threat.研发抗耐药性抗菌药物以应对全球抗菌药物耐药性威胁。
Drug Resist Updat. 2023 Jan;66:100890. doi: 10.1016/j.drup.2022.100890. Epub 2022 Nov 17.
7
Decoding the Structural Diversity: A New Horizon in Antimicrobial Prospecting and Mechanistic Investigation.解码结构多样性:抗菌药物研究与机制研究的新视野。
Microb Drug Resist. 2024 Jun;30(6):254-272. doi: 10.1089/mdr.2023.0232. Epub 2024 Apr 22.
8
Biofunctionalized Nano-antimicrobials - Progress, Prospects and Challenges.生物功能化纳米抗菌剂 - 进展、前景与挑战。
Curr Top Med Chem. 2022;22(13):1046-1067. doi: 10.2174/1568026622666211227151743.
9
Opportunities and challenges in managing antibiotic resistance in bacteria using plant secondary metabolites.利用植物次生代谢产物管理细菌抗生素耐药性的机遇与挑战。
Fitoterapia. 2020 Nov;147:104762. doi: 10.1016/j.fitote.2020.104762. Epub 2020 Oct 16.
10
Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence.细菌的抗药性:机制、进化与持续。
J Mol Evol. 2020 Jan;88(1):26-40. doi: 10.1007/s00239-019-09914-3. Epub 2019 Oct 28.

引用本文的文献

1
Repurposing of FDA-Approved Drugs to Disrupt Iron Uptake in Mycobacterium abscessus: Targeting Salicylate Synthase as a Novel Approach.重新利用美国食品药品监督管理局(FDA)批准的药物来干扰脓肿分枝杆菌的铁摄取:以水杨酸合酶为靶点的新方法
Chem Biol Drug Des. 2025 Aug;106(2):e70162. doi: 10.1111/cbdd.70162.
2
Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy.用于下一代结核病治疗的纳米增强型MbtI抑制剂
J Med Chem. 2025 Mar 13;68(5):5312-5332. doi: 10.1021/acs.jmedchem.4c02386. Epub 2025 Mar 3.
3
The diversity and applications of microbial iron metabolism and iron-containing proteins.

本文引用的文献

1
Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales.头孢地尔,一种铁载体头孢菌素,作为耐碳青霉烯类肠杆菌科细菌所致感染的一种治疗选择。
Infect Dis Ther. 2023 Mar;12(3):777-806. doi: 10.1007/s40121-023-00773-6. Epub 2023 Feb 25.
2
Targeting Siderophore-Mediated Iron Uptake in : A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria.靶向铁载体介导的铁摄取:限制非结核分枝杆菌毒力的新策略
Pharmaceutics. 2023 Feb 2;15(2):502. doi: 10.3390/pharmaceutics15020502.
3
activity of newer β-lactam/β-lactamase inhibitor combinations, cefiderocol, plazomicin and comparators against carbapenemase-producing isolates.
微生物铁代谢及含铁蛋白的多样性与应用
Commun Biol. 2025 Feb 4;8(1):177. doi: 10.1038/s42003-024-07373-1.
4
The Transcription Factor StuA Regulates Oxidative Stress-Responsive Genes in .转录因子StuA调控……中的氧化应激反应基因。 (原文结尾不完整)
Int J Mol Sci. 2024 Dec 2;25(23):12959. doi: 10.3390/ijms252312959.
5
Identification of small molecules affecting the interaction between human hemoglobin and Staphylococcus aureus IsdB hemophore.鉴定小分子对人血红蛋白与金黄色葡萄球菌 IsdB 血红素结合蛋白相互作用的影响。
Sci Rep. 2024 Apr 9;14(1):8272. doi: 10.1038/s41598-024-55931-8.
6
Structural Study of a New MbtI-Inhibitor Complex: Towards an Optimized Model for Structure-Based Drug Discovery.新型MbtI抑制剂复合物的结构研究:迈向基于结构的药物发现优化模型
Pharmaceuticals (Basel). 2023 Nov 3;16(11):1559. doi: 10.3390/ph16111559.
新型β-内酰胺/β-内酰胺酶抑制剂复方制剂头孢地尔、普拉佐米星与对照药物对产碳青霉烯酶分离株的活性。
J Chemother. 2023 Nov;35(7):596-600. doi: 10.1080/1120009X.2023.2170906. Epub 2023 Jan 27.
4
Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, Cefiderocol, and Novel Darobactin Analogs against Multidrug-Resistant Pseudomonas aeruginosa Isolates from Pediatric and Adolescent Cystic Fibrosis Patients.头孢他啶-阿维巴坦、头孢洛扎-他唑巴坦、头孢地尔、新型达罗巴坦类似物对儿科和青少年囊性纤维化患者多药耐药铜绿假单胞菌分离株的抗菌活性。
Microbiol Spectr. 2023 Feb 14;11(1):e0443722. doi: 10.1128/spectrum.04437-22. Epub 2023 Jan 24.
5
Cefiderocol against Multi-Drug and Extensively Drug-Resistant : An In Vitro Study in Poland.头孢地尔对多重耐药和广泛耐药菌的体外研究:波兰的一项研究
Pathogens. 2022 Dec 9;11(12):1508. doi: 10.3390/pathogens11121508.
6
Genomic analysis of sewage from 101 countries reveals global landscape of antimicrobial resistance.对 101 个国家污水的基因组分析揭示了全球抗微生物药物耐药性的状况。
Nat Commun. 2022 Dec 1;13(1):7251. doi: 10.1038/s41467-022-34312-7.
7
Synthesis and study of new siderophore analog-ciprofloxacin conjugates with antibiotic activities against Pseudomonas aeruginosa and Burkholderia spp.新型铁载体模拟物-环丙沙星缀合物的合成与研究,对铜绿假单胞菌和伯克霍尔德菌具有抗生素活性。
Eur J Med Chem. 2023 Jan 5;245(Pt 2):114921. doi: 10.1016/j.ejmech.2022.114921. Epub 2022 Nov 13.
8
Gallium ions incorporated silk fibroin hydrogel with antibacterial efficacy for promoting healing of -infected wound.镓离子掺入丝素蛋白水凝胶具有抗菌功效,可促进感染伤口愈合。
Front Chem. 2022 Oct 28;10:1017548. doi: 10.3389/fchem.2022.1017548. eCollection 2022.
9
Boosting lung accumulation of gallium with inhalable nano-embedded microparticles for the treatment of bacterial pneumonia.利用可吸入的纳米包埋微粒提高镓在肺部的蓄积以治疗细菌性肺炎。
Int J Pharm. 2022 Dec 15;629:122400. doi: 10.1016/j.ijpharm.2022.122400. Epub 2022 Nov 13.
10
Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections.水杨酸合酶(Mbti)抑制剂的体外和离体活性的合成与评估:作为治疗分枝杆菌感染的新候选药物
Pharmaceuticals (Basel). 2022 Aug 11;15(8):992. doi: 10.3390/ph15080992.